TPM3 was specifically amplified in endometrioid tumors and the gene has been shown to constitute a fusion gene with NTRK1 which belongs to the group of TRK oncogenes reported for papillary thyroid carcinoma[32]. This evidence concerns the gene NTRK1 and thyroid gland papillary carcinoma.